XML 31 R24.htm IDEA: XBRL DOCUMENT

Leases

9 Months Ended

Sep. 30, 2025

16.

Leases

The Company has operating leases for corporate and medical offices. These leases have remaining lease terms ranging from 7 months to 20 years, some of which may include options to extend the leases for up to ten years, and some of which may include options to terminate the leases within one year. These leases consist of payments that are fixed or variable. Variable lease payments are based on an index or a rate such as the Consumer Price Index.

Operating lease costs for the three months ended September 30, 2025 and 2024 were $4.7 million and $3.2 million, respectively. Operating cash flows from operating leases for the three months ended September 30, 2025 and 2024 were $3.9 million and $3.1 million, respectively. Operating lease costs for the nine months ended September 30, 2025 and 2024 were $11.9 million and $9.4 million, respectively. Operating cash flows from operating leases for the nine months ended September 30, 2025 and 2024 were $10.1 million and $8.7 million, respectively.

Leases with an initial term of 12 months or less are not recorded on the condensed consolidated balance sheets.

Other information related to operating leases was as follows:


	Nine Months Ended September 30,
	2025			2024

Weighted Average Remaining Lease Term	6.35 years			6.93 years

Weighted Average Discount Rate		6.79	%		6.68	%

The following are future minimum lease payments under non-cancellable operating leases for the years ending December 31 (in thousands):


	Operating Leases
2025 (excluding the nine months ended September 30, 2025)	$	2,362
2026		9,292
2027		7,859
2028		6,927
2029		5,420
Thereafter		15,066

Total future minimum lease payments		46,926
Less: imputed interest		9,574
Total lease liabilities		37,352
Less: current portion		7,181
Long-term lease liabilities	$	30,171